Cargando…

Food products as potential carriers of SARS-CoV-2

At present, humanity is confronting with a novel life-threatening challenge from the COVID-19 pandemic infectious disease caused by the novel coronavirus SARS-CoV-2. To date, the various transmission modes of SARS-CoV-2 have not been completely determined. Food products might be carriers for SARS-Co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yekta, Reza, Vahid-Dastjerdi, Leily, Norouzbeigi, Sahar, Mortazavian, Amir M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656178/ https://www.ncbi.nlm.nih.gov/pubmed/33199941 http://dx.doi.org/10.1016/j.foodcont.2020.107754

Ejemplares similares

Stability of SARS‐CoV‐2 as consequence of heating and microwave processing in meat products and bread
por: Norouzbeigi, Sahar, et al.
Publicado: (2021)

Medicinal Food Products; a New Approach from Ordinary Foods to Medicine
por: M. Mortazavian, Amir, et al.
Publicado: (2016)

Challenges of managing the asymptomatic carriers of SARS-CoV-2
por: Rahimi, Farid, et al.
Publicado: (2020)

Profiling of Initial Available SARS-CoV-2 Sequences from Iranian Related COVID-19 Patients
por: Salehi, Najmeh, et al.
Publicado: (2020)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
por: Verma, Surjeet, et al.
Publicado: (2020)

On the deformation and frequency analyses of SARS-CoV-2 at nanoscale
por: Dastjerdi, Shahriar, et al.
Publicado: (2022)

Particulate matter (PM(2.5)) as a potential SARS-CoV-2 carrier
por: Nor, Norefrina Shafinaz Md, et al.
Publicado: (2021)

Influenza Vaccine and COVID-19 Pandemic: Could This Vaccine Help Limit the Potential Adverse Consequences of SARS-CoV-2?
por: Mosaed, Reza, et al.
Publicado: (2022)

Unclear but present danger: An asymptomatic SARS-CoV-2 carrier
por: Yu, Xuejing, et al.
Publicado: (2020)

A study on infectivity of asymptomatic SARS-CoV-2 carriers
por: Gao, Ming, et al.
Publicado: (2020)

Duration of SARS-CoV-2 viral RNA in asymptomatic carriers
por: Yan, Xiquan, et al.
Publicado: (2020)

Lung ultrasonography unmasking the asymptomatic SARS-CoV-2 carrier
por: Tung-Chen, Yale, et al.
Publicado: (2021)

Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers
por: Murata, Takayuki, et al.
Publicado: (2021)

Lung ultrasonography unmasking the asymptomatic SARS-CoV-2 carrier
por: Tung-Chen, Yale, et al.
Publicado: (2021)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients
por: Kim, Seong Eun, et al.
Publicado: (2020)

Clinical characteristics and infectivity of asymptomatic carriers of SARS-CoV-2 (Review)
por: Zhang, Wanying, et al.
Publicado: (2021)

Screening for SARS-CoV-2 carriers: What about saliva tests?
Publicado: (2020)

SARS-CoV-2 and Risk to Food Safety
por: Anelich, Lucia E. C. M., et al.
Publicado: (2020)

The Necessity of Stool Examination in Asymptomatic Carriers as a Strategic Measure to Control Further Spread of SARS-CoV-2
por: Mirjalali, Hamed, et al.
Publicado: (2020)

A Review of Virus-Like Particle-Based SARS-CoV-2 Vaccines in Clinical Trial Phases
por: Sharifzadeh, Mohammad, et al.
Publicado: (2022)

Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV
por: V. K., Priya, et al.
Publicado: (2021)

Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers
por: Shental, Noam, et al.
Publicado: (2020)

Asymptomatic SARS-CoV-2 Carriers: A Systematic Review and Meta-Analysis
por: Syangtan, Gopiram, et al.
Publicado: (2021)

Saliva TwoStep for rapid detection of asymptomatic SARS-CoV-2 carriers
por: Yang, Qing, et al.
Publicado: (2021)

Saliva TwoStep for rapid detection of asymptomatic SARS-CoV-2 carriers
por: Yang, Qing, et al.
Publicado: (2021)

The Value of Rapid Antigen Tests for Identifying Carriers of Viable SARS-CoV-2
por: Shidlovskaya, Elena V., et al.
Publicado: (2021)

Effect of carrier yeast RNAs in the detection of SARS-CoV-2 by RT-LAMP
por: Morais-Armas, Samantha, et al.
Publicado: (2023)

Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients
por: Rostamzadeh, Davood, et al.
Publicado: (2021)

SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms
por: Shoraka, Shahrzad, et al.
Publicado: (2021)

Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents
por: Kim, Cheorl-Ho
Publicado: (2021)

Potential SARS-CoV-2 vaccines: Concept, progress, and challenges
por: Hosseini, Seyede Atefe, et al.
Publicado: (2021)

Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing
por: Krishnamoorthy, Pandikannan, et al.
Publicado: (2021)

The Performance of SARS-CoV-2 Serology Testing in the Diagnosis of COVID-19
por: Abdollahi, Alireza, et al.
Publicado: (2022)

The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV
por: Hemmat, Nima, et al.
Publicado: (2021)

Relevance of SARS-CoV-2 in food safety and food hygiene: potential preventive measures, suggestions and nanotechnological approaches
por: Ceylan, Zafer, et al.
Publicado: (2020)

Potential Pathogenicity Determinants Identified from Structural Proteomics of SARS-CoV and SARS-CoV-2
por: Prates, Erica T, et al.
Publicado: (2020)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)

Viral Transmission and Clinical Features in Asymptomatic Carriers of SARS-CoV-2 in Wuhan, China
por: Tan, Fen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uvsd9210c3uai1r5maf27t0ln2